FDA Approvals - FDA approves Lannett's ANDA for Hydrochlorothiazide Capsules, 12.5 mgLannett Company,
FDA approves Lannett's ANDA for Hydrochlorothiazide Capsules, 12.5 mg
Lannett Company, Inc. today announced it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Hydrochlorothiazide Capsules, 12.5 mg.